Unveiling Insights: suPAR News – European Perspectives and Innovations in Acute Care

Fri Jun 07 2019

Explore the first edition of “suPAR News”, featuring a collection of ten captivating articles and interviews across Europe.

Among other articles, you can read these:

  • “suPAR: An important tool in acute care”, where Dr. Ariel Lindo and Dr Miguel Callejas, from the Hospital Villarrobledo Albacette in Spain, have tested suPAR on 200 patients in the ED.

    “The usefulness of suPAR in the ED decision making is not only validated via the literature but also via the test we have carried out just now. We have found that suPAR is surely an important prognostic tool for the ED”, says Dr. Lindo
    .“Yes, when someone is deciding about discharging a patient, the value we get from suPAR is important”,adds Dr. Callejas.
  • “Heads up: The heat is on in Spain”, introduces Dr. Juan Gonzalez del Castillo, a PhD leading a suPAR project at the Emergency Department of Hospital Clinico San Carlos in Madrid, renowned as one of Spain’s premier medical institutions.“It is essential to have the help of biomarkers, such as suPAR, which can support the discharge decision and give us the confidence that we are doing the right thing. Patients evaluated in the ED are increasingly complex, older, and with more accumulated comorbidities. This translates into atypical clinical presentations complicating the decision-making.
    For this reason, it is essential to have the help of biomarkers, such as suPAR, which can support the discharge decision and give us the confidence that we are doing the right thing.” , says Dr. Juan Gonzalez.
    Four medical facilities in Asturias, Basque Country, Aragon, and Madrid are initiating a suPAR pilot program to test the novel turbidimetric technique for suPAR measurement, known as TurbiLatex, on their cobas analyzers.
  • “Speed and efficiency: TurbiLatex sets a new standard for suPAR”, talks about our new suPAR test, measured on a turbidimetric platform and how it works.

Read all these articles and many more, in the first issue of “suPAR News“. You can see the journal here.

Let us know if you would like a printed copy – contact us at info@virogates.com

suPAR News vol. 1 frontpage

900+

published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of 4 products:

Quick Triage

A Point of Care Solution

TurbiLatex

For Automated Systems

ELISA Assay

Clinical and Research

suPARnostic POC+

POC+

Point-of-care finger prick

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates